Phase I Study of the Safety and Preliminary Efficacy of Intracerebral Transplantation of HuCNS-SC Cells for Connatal Pelizaeus-Merzbacher Disease (PMD)

Trial Profile

Phase I Study of the Safety and Preliminary Efficacy of Intracerebral Transplantation of HuCNS-SC Cells for Connatal Pelizaeus-Merzbacher Disease (PMD)

Completed
Phase of Trial: Phase I

Latest Information Update: 02 Aug 2013

At a glance

  • Drugs Adult neural stem cells (Primary)
  • Indications Pelizaeus-Merzbacher disease
  • Focus Adverse reactions
  • Sponsors StemCells
  • Most Recent Events

    • 02 Aug 2013 Two-year data was presented at the 2013 Pelizaeus-Merzbacher Disease Symposium and Health Fair, according to a StemCells media release.
    • 21 Mar 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top